Loading company…
MB Therapeutics uses 3D printing to make personalized medicines with tailored doses and drug forms.
MB Therapeutics develops 3D printing technologies for personalized medicines, including tailored doses and drug forms that can combine multiple active ingredients. Its intended clients include pharmaceutical companies and healthcare providers. Founded in 2023, the company is based in Montpellier, France. In February 2025, it raised EUR 2 million in seed funding led by Beprep, with participation from Angels Santé, Bpifrance, and Calyseed.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in